Sort
130,381 grants matching “hiv”
US MILITARY HIV RESEARCH
$2,265,729,366The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2011 · Defense Health Agency
ADDRESSING THE THREATS OF HIV AND EMERGING INFECTIOUS DISEASE TO THE MILITARY AND GLOBAL COMMUNITY THROUGH INNOVATIVE RESEARCH
$800,631,761The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2018 · Defense Health Agency
HVTN 405/HPTN 1901 Characterizing SARS-CoV-2-specific immunity in convalescent individuals
$393,953,893Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
US MILITARY HUMAN IMMONODEFIECIENCY VIRUS (HIV) RESEARCH PROGRAM
$232,794,889The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2008 · Department of the Army
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
$181,942,638Judith S. Currier · University Of California Los Angeles · UM1 · FY2020 · AI
CoVPN Vaccine Site Preparation
$169,587,659Myron S Cohen · Family Health International · UM1 · FY2020 · AI
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
$128,882,815Wafaa M. El-Sadr · Columbia University Health Sciences · U62 · FY2010 · PS
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
$127,703,044Wafaa M. El-Sadr · Columbia University Health Sciences · U62 · FY2008 · PS
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
$113,247,929Wafaa M. El-Sadr · Columbia University Health Sciences · U62 · FY2009 · PS
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
$98,478,934Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn · U62 · FY2009 · PS
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
$91,873,485Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn · U62 · FY2010 · PS
U.S. MILITARY HUMAN IMMUNODEFICIENCY VIRUS (HIV) RESEARCH PROGRAM
$87,925,336The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2008 · Department of Defense
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
$87,385,113Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn · U62 · FY2008 · PS
LOC: HIV Prevention Trials Network
$84,256,416Myron S Cohen · Family Health International · UM1 · FY2018 · AI
Clinical Studies Core
$81,242,031David D. McManus · Univ Of Massachusetts Med Sch Worcester · U54 · FY2020 · HL
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
$76,222,582Judith S. Currier · University Of California Los Angeles · UM1 · FY2023 · AI
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
$74,804,595Wafaa M. El-Sadr · Columbia University Health Sciences · U62 · FY2007 · PS
HIV Prevention Trials Network Leadership and Operations Center
$70,307,771Myron S Cohen · Family Health International · UM1 · FY2021 · AI
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
$70,272,083Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn · U62 · FY2007 · PS
Establishment and operation of a Vaccine Pilot Plant
$66,352,968Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2024 · AI
Establishment and operation of a Vaccine Pilot Plant
$66,062,291Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2023 · AI
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
$61,429,109Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
$60,609,395Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2018 · AI
RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR
$60,326,046Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn · U62 · FY2006 · PS
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
$56,989,695Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2017 · AI